Bringing Engineers to Medicine with Dr. Ron Davis, Stanford Genome Center
Submitted by Theral Timpson on Thu, 11/17/2011 - 12:40Podcast Sponsor: Ingenuity - The fastest way to obtain biological meaning from your expression data. Get a free iReport
Guest:
Dr. Ron Davis, Director, Stanford Genome Technology Center, Bio and Contact Info
Listen (2:04) Money from prize to research chronic fatique syndrome
Listen (6:48) Bringing engineers to clinical medicine
Listen (8:04) Fit between university lab and commercial development
Listen (5:47) Fan of targeted analysis of genome
Listen (3:17) Should scientists engage general public?
Listen (6:32) What about technology drives you?
Listen (3:29) Is NIH funding academic welfare?
Listen (11:18) Thoughts on 'open science'
Listen (1:33) How do you characterize yourself?
We’re delighted to welcome to mendelspod a veteran of the life science arena, Dr. Ron Davis. He’s the director of the Stanford Genome Technology Center and winner of this year’s Gruber Genetics Prize. The prize was presented to Ron a couple weeks ago at the ASHG ho-down in Montreal. Ron has been a leader in the area of genomics and high throughput biochemical techniques and been involved in the spinoff of multiple start-up companies from his lab at Stanford. He’s a co-founder of ParAllele, a company later purchased by Affymetrix and is former advisor to Ion Torrent, whose semiconductor sequencing technology is dramatically reducing the cost of sequencing.
Ron shares with us some of the current technology that he's working on and talks about how he goes about it. In a very candid interview, Ron talks about issues around NIH funding and the growing 'open science' movement.
